Clinical Trials Directory

Trials / Terminated

TerminatedNCT01331499

Salient Aquamantys Spine Trial

A Post-Market, Prospective, Multicenter, Randomized Trial Comparing the Use of Standard of Care Blood Sparing Techniques With and Without the Aquamantys System to Facilitate Hemostasis in Subjects Undergoing Multi-level Spinal Fusions

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Salient Surgical Technologies · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare standard of care hemostasis techniques with and without the use of Aquamantys in reducing peri-operative blood loss.

Detailed description

The primary objective of the study is to assess the effectiveness of Aquamantys in reducing peri-operative blood loss compared with standard electrocautery Secondary objectives include : * Rate and volume of transfusions * Evaluating the reduction in hemoglobin and hematocrit values post- operatively * LOS costs, and operative time * Gathering operator feedback on qualitative criteria, including ease of use and surgical visualization between the two treatment groups

Conditions

Interventions

TypeNameDescription
DEVICEBipolar Sealer (Aquamantys)Standard of care blood sparing techniques along with the use of bipolar sealer
PROCEDUREStandard of CareStandard of care blood sparing techniques without the useof bipolar sealer

Timeline

Start date
2011-04-01
Primary completion
2012-12-01
Completion
2013-04-01
First posted
2011-04-08
Last updated
2012-06-07

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01331499. Inclusion in this directory is not an endorsement.

Salient Aquamantys Spine Trial (NCT01331499) · Clinical Trials Directory